Matches in Wikidata for { <http://www.wikidata.org/entity/Q85309234> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q85309234 description "artikull shkencor i botuar më 01 shkurt 2013" @default.
- Q85309234 description "artículu científicu espublizáu en febreru de 2013" @default.
- Q85309234 description "im Februar 2013 veröffentlichter wissenschaftlicher Artikel" @default.
- Q85309234 description "scientific article published on 01 February 2013" @default.
- Q85309234 description "wetenschappelijk artikel" @default.
- Q85309234 description "наукова стаття, опублікована в лютому 2013" @default.
- Q85309234 name "Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors" @default.
- Q85309234 name "Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors" @default.
- Q85309234 name "Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors" @default.
- Q85309234 type Item @default.
- Q85309234 label "Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors" @default.
- Q85309234 label "Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors" @default.
- Q85309234 label "Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors" @default.
- Q85309234 prefLabel "Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors" @default.
- Q85309234 prefLabel "Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors" @default.
- Q85309234 prefLabel "Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors" @default.
- Q85309234 P1433 Q85309234-FAD88F13-943B-4314-AD96-47F2B6038E48 @default.
- Q85309234 P1476 Q85309234-EE3BC907-4B5B-4BEE-8BBD-A8DEEC6E4E7E @default.
- Q85309234 P2093 Q85309234-066375BF-D0B1-4D2E-B2AE-A024B520CCAF @default.
- Q85309234 P2093 Q85309234-1084BF1B-FAA3-4AA6-B446-DBE2E232DDD1 @default.
- Q85309234 P2093 Q85309234-192294F2-43D3-43A9-8800-91FAA3EC4CFA @default.
- Q85309234 P2093 Q85309234-521772C0-1FFC-4688-89D0-F0406F770494 @default.
- Q85309234 P2093 Q85309234-5F65FAF1-3CD5-430E-8F7B-FF03BE1C1360 @default.
- Q85309234 P2093 Q85309234-7AFBE8AF-2DD1-4D21-AA07-290B3B9870DF @default.
- Q85309234 P2093 Q85309234-CCCDAC74-1B7B-4226-AB95-9B07968A3DA1 @default.
- Q85309234 P2093 Q85309234-E566EC4E-9BB0-439D-B4AA-C0039E0A680F @default.
- Q85309234 P2093 Q85309234-F456152F-059B-45E1-A1E5-FF2EAAED125A @default.
- Q85309234 P304 Q85309234-DC10F909-7998-4FB3-97EA-86814822651E @default.
- Q85309234 P31 Q85309234-7218D505-A9F8-4D14-A425-55B341FA0977 @default.
- Q85309234 P356 Q85309234-933C22FC-BDAD-40AF-821A-C0BF8CABECB2 @default.
- Q85309234 P433 Q85309234-B12C7F2E-E74C-42A7-8929-FC585967CAA1 @default.
- Q85309234 P478 Q85309234-0119C868-3039-4AED-854A-116CB6EE8041 @default.
- Q85309234 P577 Q85309234-E7FC131D-D714-4BD6-BE74-008A3BF4F029 @default.
- Q85309234 P698 Q85309234-0A466B76-6F14-4CE2-96A9-A9936346B013 @default.
- Q85309234 P356 MEG.0B013E328359D1A6 @default.
- Q85309234 P698 23108416 @default.
- Q85309234 P1433 Q15746143 @default.
- Q85309234 P1476 "Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors" @default.
- Q85309234 P2093 "Anne Couvelard" @default.
- Q85309234 P2093 "Catherine Lombard-Bohas" @default.
- Q85309234 P2093 "Guillaume Cadiot" @default.
- Q85309234 P2093 "Marie-Pierre Vullierme" @default.
- Q85309234 P2093 "Maxime Palazzo" @default.
- Q85309234 P2093 "Olivia Hentic" @default.
- Q85309234 P2093 "Philippe Ruszniewski" @default.
- Q85309234 P2093 "Tamara Matysiak-Budnik" @default.
- Q85309234 P2093 "Vinciane Rebours" @default.
- Q85309234 P304 "232-238" @default.
- Q85309234 P31 Q13442814 @default.
- Q85309234 P356 "10.1097/MEG.0B013E328359D1A6" @default.
- Q85309234 P433 "2" @default.
- Q85309234 P478 "25" @default.
- Q85309234 P577 "2013-02-01T00:00:00Z" @default.
- Q85309234 P698 "23108416" @default.